Axogen (AXGN) Depreciation & Amortization (IS) (2010 - 2011)
Axogen's quarterly Depreciation & Amortization (IS) came in at $44427.0 in Q3 2011, down 18.06% year-on-year from $54220.0 in Q3 2010, and down 18.06% quarter-over-quarter from $54220.0 in Q3 2010.
Axogen has reported Depreciation & Amortization (IS) for 2 years, with the latest figure at $44427.0 in Q3 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 310.25 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2011 | 44,427.00 |
| Sep 30, 2010 | 54,220.00 |